The largest database of trusted experimental protocols

Lentiviral shrnas

Manufactured by Merck Group
Sourced in United States

Lentiviral shRNAs are a type of laboratory equipment used to deliver short hairpin RNA (shRNA) sequences into cells. shRNAs are designed to target and silence specific genes, enabling researchers to study gene function and knockdown gene expression. These lentiviral constructs provide a efficient method for introducing shRNA into a variety of cell types, including hard-to-transfect primary cells.

Automatically generated - may contain errors

10 protocols using lentiviral shrnas

1

Lentiviral shRNA Knockdown of MCPIP1 and Related Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three lentiviral shRNAs targeting human MCPIP1 mRNA and the lentiviral shRNAs targeting the mRNAs of BCL2, RELB, BCL3, FAS and DEDD2 were obtained from Sigma (St. Louis, MO). The #1 MCPIP1 shRNA targets CDS (NM_025079.1-1777s1c1), #2 targets 3’UTR (NM_025079.1-2532s1c1), and #3 targets CDS (NM_025079.1-260s1c1). A scramble non-targeting shRNA was used as control. Lentiviral particles were packaged in HEK293T cells by co-transfecting shRNA-pLKO.1, pCMV-dR8.2, and pMD2.G constructs. 48 h later, supernatants were collected and centrifuged to discard cell debris. For infection, virus supernatants with 1 μg/ml Polybrene were added to MDA-MB-231 and MDA-MB-453 cells for overnight. After two rounds infection, the infected cells were selected with puromycin (2.5 μg/ml) for 2 weeks, followed by experimental analysis.
+ Open protocol
+ Expand
2

Lentiviral shRNA Knockdown of Roquin1, MCM2, and Cyclin E1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two lentiviral shRNAs (NM_172071.1–3458s1c1; NM_172071.1-2032s1c1) targeting human Roquin1 mRNA and two lentiviral shRNAs targeting human MCM2 (NM_004526.2-2553s21c1) and Cyclin E1 (NM_001238.1-1149s1c1) were purchased from Sigma. A scramble control shRNA was used as a control. Lentiviral particles were packaged in HEK293T cells by co-transfecting shRNA-pLKO.1, pCMV-dR8.2, and pMD2.G constructs. After 48 h, virus supernatants were collected and centrifuged to discard cell debris, and then added to target cells with 1 μg/mL polybrene for overnight. After two rounds infection, the target cells were selected with puromycin (2.5 μg/mL) for 2 weeks, followed by further study.
+ Open protocol
+ Expand
3

Lentiviral Knockdown of Roquin2, PDGFC, and EDN1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two lentiviral shRNAs (NM_018835.2-475s21c1; NM_018835.2-725s21c1) targeting human Roquin2 mRNA and two lentiviral shRNAs targeting human PDGFC (NM_016205.1-831s1c1) and EDN1 (NM_001955.x-677s1c1) were purchased from Sigma. A scramble control shRNA was used as a control. Lentiviral particles were packaged in HEK293T cells by cotransfecting shRNA-pLKO.1, pCMV-dR8.2, and pMD2.G constructs. After two rounds infection, the target cells were selected with puromycin (2.5µg/mL) for two weeks, followed by further study.
+ Open protocol
+ Expand
4

Knockdown and Restoration of Key Signaling Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
For AMPK, CaMKKβ, LKB1, and Skp2 knockdown, lentiviral packing plasmid and pLKO.1-puro-shRNA constructs (Sigma) were transfected into 293T cells using calcium phosphate method. After 36 h, the supernatant was collected, and MDA231 parental cells were infected and 2 µg/ml puromycin selected for a week. Knockdown efficiency was detected by western blot. For Skp2 WT, S256A, and S256D restore cell, Skp2 was cloned into pLKO.1 vector (Sigma). Mutants were generated by site-direct mutagenesis. The following lentiviral shRNAs (Sigma) are used: shLuc 5′-CGCTGAGTACTTCGAAATGTC; shSkp2-1 5′-GATAGTGTCATGCTAAAGAAT; shSkp2-2 5′-GCCTAAGCTAAATCGAGAGAA; shCaMKKβ 5′-CCGGGTGAAGACCATGATACGTAAACTCGAGTTTACGTATCATGGTCTTCACTTTTT; shLKB1 5′-CATCTACACTCAGGACTTCAC; shAMPKα1-1 5′-CCGGGTTGCCTACCATCTCATAATACTCGAGTATTATGAGATGGTAGGCAACTTTTT; shAMPKα1-2 5′-CCGGGTAGCTGTGAAGATACTCAATCTCGAGATTGAGTATCTTCACAGCTACTTTTTTG
For restoration experiments, we transiently transfected 5–10 μg DNA with turbofect (Thermo Fisher, R0531) into Skp2-/- MEF cells, AMPKα-/- MEF cells and CaMKKβ stably knockdown MDA-MB-231 cells, the detailed information was described in each figure legend.
+ Open protocol
+ Expand
5

Lentiviral Knockdown of AHR and ATF4

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentiviral shRNAs targeting AHR and non-targeting control were obtained from Sigma-Aldrich (St. Louis, MO, USA). Following transduction, H1975 cell lines were selected with 0.5 µg/ml puromycin for 7 days. Clones were established from the transduced populations using limiting dilution. After lentiviral transduction of cells with EGFP-ffluc-epHIV7 vector, GFP-positive cells were isolated using fluorescence-activated cell sorting.
For transient knockdown of ATF4, specific MISSION® esiRNA (Sigma-Aldrich, Munich, Germany) and MISSION® siRNA Universal Negative Control were introduced by RNAiMAX (Thermo Fischer Scientific, Waltham, MA, USA) according to the manufacturer’s protocol.
For sequences of shRNAs and siRNAs see Supplementary Table 2.
+ Open protocol
+ Expand
6

siRNA Transfection and Lentiviral Knockdown in Osteoclastogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For siRNA transfection, BMMs or C2C12 myoblasts in proliferation were transfected with siRNA (50 nM/transfection) using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer’s instructions. Cells were transfected again the next day and then 6 h after differentiation with RANKL and M-CSF. siRNAs were purchased from Integrated DNA Technologies (Dnm2) and Ambion (CHC). Lentiviral shRNAs with a puromycin resistance gene were produced or purchased from Sigma-Aldrich (Dnm2) and OriGene (CHC). BMMs or C2C12 myoblasts infected with lentiviruses were selected with puromycin and cultured 3–4 d for differentiation. Cells were then harvested for Western blot analyses or fixed for TRAP or H&E staining.
+ Open protocol
+ Expand
7

Lentiviral shRNA Transduction in Neuronal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentiviral shRNAs (Sigma-Aldrich) were thawed on ice and diluted in fresh medium and added onto the cells at DIV2. The 2.5 multiplicity of infection for both sham control (Sigma-Aldrich; SHC002) and syn-shRNAs (Sigma-Aldrich; SCHLNV-01201610MN; TRCN0000366590) was used based on the multiplicity of infection titration. At DIV3, the medium was replaced with fresh culture medium. Cells were transduced with AD PHFs or α-syn mpffs at DIV7 for 14 d and fixed at DIV21.
+ Open protocol
+ Expand
8

Retroviral and Lentiviral Transduction

Check if the same lab product or an alternative is used in the 5 most similar protocols
pBabe-GFP empty vector or pBabe-GFP-MYC vector63 (link), pMX-T7-2xFlag empty vector or pMX-T7-2xFlag-Menin vector (gift from Dr Xianxin Hua in University of Pennsylvania)64 (link) was co-transfected with plasmids encoding gag/pol and VSVG into HEK293T packaging cells using lipofectamine 2000 (Invitrogen). HT1080 cells were infected with produced retrovirus in the presence of polybrane and selected with 0.5 mg ml−1 G418 or 0.5 μg ml−1 puromycin to establish stale cells. Lentiviral shRNAs targeting human MYC, MEN1, ASH2L, RBBP5, CDK9, Cyclin T1 and SCD1 were purchased from Sigma. shRNA targeting sequences are listed in Supplementary Table 1. Viruses expressing shRNAs were produced in HEK293T cells and infected HT1080 or HepG2 cells in the presence of polybrane.
+ Open protocol
+ Expand
9

Lentiviral Knockdown of Roquin1, MCM2, and Cyclin E1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two lentiviral shRNAs (NM_172071.1-3458s1c1; NM_172071.1-2032s1c1) targeting human Roquin1 mRNA and two lentiviral shRNAs targeting human MCM2 (NM_004526.2-2553s21c1) and Cyclin E1 (NM_001238.1-1149s1c1) were purchased from Sigma. A scramble control shRNA was used as a control. Lentiviral particles were packaged in HEK293T cells by co-transfecting shRNA-pLKO.1, pCMV-dR8.2, and pMD2.G constructs. After 48 h, virus supernatants were collected and centrifuged to discard cell debris, and then added to target cells with 1 µg/mL polybrene for overnight. After two rounds infection, the target cells were selected with puromycin (2.5 µg/mL) for two weeks, followed by further study.
+ Open protocol
+ Expand
10

Lentiviral Knockdown and Overexpression of HuR and HOTAIR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two lentiviral shRNAs targeting human HuR and HOTAIR were obtained from Sigma (St. Louis, MO). The HuR shRNA targets CDS (U38175.1), HOTAIR shRNA targets mRNA (NR_047518.1). A scramble non-targeting shRNA was used as control. The shRNA sequences were inserted into pLKO.1. Meanwhile, HuR CDS and HOTAIR sequences were inserted into pLVX-IRES-ZsGreen1, named as Lenti-HuR-CDS and Lenti-HOTAIR. Lentiviral particles were packaged in HEK293T cells by co-transfecting shRNAs-pLKO.1 or Lenti-HuR-CDS or Lenti-HOTAIR, pCMV-dR8.2 and pMD2.G constructs. 72 h later, supernatants were collected and centrifuged to remove cell debris. For infection, virus supernatants with 2 µg/ml Polybrene were added to SCC25 and FaDu cells for 72 h. After two rounds infection, the infected cells were selected with puromycin (Sigma, 2 µg/ml) for 2 weeks, followed by qRT-PCR and western blot verification. Fluorescent cell sorting was used to select cells infected with Lenti-HuR-CDS or Lenti-HOTAIR.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!